Predicted impact of atrial flow regulator on survival in heart failure with reduced and preserved ejection fraction.
Lucas LauderMartin W BergmannChristina PaitazoglouRamazan ÖzdemirChristos IliadisJozef BartunekAlexander LautenThomas KellerStephan WeberHorst SievertStefan D AnkerFelix MahfoudPublished in: ESC heart failure (2023)
In patients with HFpEF, the mortality rate following AFR implantation was lower than the predicted mortality rate. Dedicated randomised, controlled trials are needed - and currently ongoing - to investigate whether the AFR improves mortality.